Countdown 10 days! Five exciting keynote speeches of the Kingsbury Cell Gene Therapy Industry Development and Cooperation Forum

Read: Countdown 10 days!at the J.PMorgan Healthcare Conference (JPM), the world's top healthcare investment and financing event, Kingsley as a leader in the cell gene therapy industry held the Kingsbury Biotech Global Industry Forum, a unique "Chinese biopharmaceutical force" to the world stage, and by the world's attention and recognitionAmong them, "the exploration of cell and gene therapy from technological innovation to industry and commercialization" has become one of the hot topicsKingsray Gene Gene Therapy Industry Development and Cooperation Forum was born, will be held on Friday, July 17, 2020 in Shanghai Pudong Shangri-La Hotel, has entered the countdown! At that time, the conference will be "five keynote speeches" as the main topic, all-round exploration of the field of cell genetics on process development, regulatory policy, reporting experience, commercial development and other hot topics, for the scene guests to build a communication bridge, promote communication and dialogue, the common language cell gene development in the futureIn this particular period of this year, a few offline industry exchange opportunities, we invite you to celebrate!Keynote Speech I: Cell Immunotherapy Industry Trends and Policy Environment InterpretationSpeaker: Fu Dazhao, Director of Shanghai Biopharmaceutical Science and Technology Industry Promotion Center
Global Cell Gene Industrialization Process is accelerating, cell therapy industry is China's most potential counterpart sander Europe and the United States biopharmaceutical field, opportunities and challenges coexist, practitioners need to challenge not only the continuous updating of technology, technology to industrialization of the exploration, the United States and Europe cell treatment approval and changes in the market and regulatory policy What about the future? Fu Dazhao, director of Shanghai Biopharmaceutical Technology Industry Promotion Center, will bring his unique insights, which are worth looking forward tokeynote speech two: CAR-T treatment multiple myeloma clinical trial design experience and breakthroughspeaker: Professor Yan Jianqing, Shanghai Jiaotong University Medical School affiliated with Ruijin Hospital Department of HemalogyIn recent years, CAR-T cell technology has achieved encouraging results, and targeted BCMA CAR-T precision cell therapy, the emergence of multiple myeloma clinical treatment and even the entire tumor treatment has had a rapid and far-reaching impactTogether with CD19 CAR-T, the clinical treatment of tumors has officially entered the "precision, immune, live drug" phaseWhat will be the breakthrough in CAR-T's treatment of multiple myeloma? Professor Yan Jianqing, Deputy Director of The Department of Haematology at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, will appear at the general assembly to talk to everyone about the future of CAR-T treatment of multiple myelomaKeynote Speech 3: The sudden arrival of the era of gene and cell therapy has led to the emergence of China's biopharmaceutical industry towards original innovation
speaker: Dr Fan Xiaohu, legendary biological chief scientific officer in recent years, China's biopharmaceutical industry has undergone a qualitative change, the industry has entered an innovative and active period, opened a new era, China has the potential to develop and commercialize cell/gene products, and is expected to make breakthrough progress in the application of solid tumor research, the arrival of a new era of has also given birth to the original innovation of cell/gene products, which is a trend in the future, but also the enterprise's fundamental, cell/gene industry progress, can not be separated from the development process of each local innovation, in the sudden arrival of the new era, want to enter the fast lane, how to play better advantage? In this particular period of this year, a few opportunities for communication, the conference legendary chief scientific officer Dr Fan Xiaohu will bring you a big trend under the in-depth analysis, the direction of China's biopharmaceutical industry, please look forward to Keynote 4: Riding the Gene Therapy Roller: Journey Through Tech
Transfer to Commercialization Speaker: Ian Carmichael, Vice President of Merck, General Manager of Process Solutions China
The rapid development of cell/gene therapy technology has also brought the capital competition, how to guarantee and control costs, become the biggest challenge of cell/gene technology to quickly realize the commercialization of industrialization, and how to optimize the process Reducing costs, how to shorten the development cycle, how to promote the formation of the future of China's capital industry pattern and other issues become the focus, Merck Vice President, Process Solutions China General Manager Ian Carmichael, will be from an objective point of view, around everyone's concern about process technology, quality control, cost control and other issues, set up a multi-angle to share his valuable experience Keynote 5: Cell and Gene Therapy Outsourcing Success Factors Speaker: Fredy Chu, GenScript ProBio QA and QC VP With the rapid growth of the cell/gene industry, the corresponding CDMO outsourcing demand has accelerated in recent years, and is expected to reach more than $3.6 billion by 2022 and produce a number of global heavyweight products CDMO's involvement can spread the potential risks in drug development, reduce costs and shorten the development cycle, where quality quality management strategies are key to a win-win situation How should participants in biologics choose suppliers, what issues need attention, and how do they evaluate their strategies? Fredy Chu, Vice President of Quality Control at Kingsley, takes us to explore the success factors of CDMO online conference registration channel will be closed on July 16 Sweep the code to attend the meeting, face-to-face communication with Big Curry! contact us : Tel: 025-58895776-6321 /3167 Email:event@genscript.com